The LEAD study or Laser Intervention in early stages of age-related macular degeneration (AMD) trial was a world-first study into the safety and efficacy of the 2RT laser as a possible treatment for people with earlier stages of AMD to slow or prevent progression to late-stage AMD.
Create a free Member account at NZ Optics to read this article and more.
US neuro-optometrist Dr Bryce Appelbaum's brain-based vision training model improved UK GP Dr Rangan Chatterjee's una
An optometrist recounts her experience on an Eyes4Everest outreach trip to Nepal's Annapurna region, providing eyecare at high-altitude
Veteran Auckland optometrist Trevor Skinner retires after nearly 50 years, known for his patient-first approach, empathy, and passion for optometry, having
Artificial intelligence (AI) use in eyecare is moving fast, but are regulation, ethics and real-world integration keeping pace? As clinicians and regulators grapple with how to harness its potential without compromising patient safety or equity, Drew Jones examines where AI use in eyecare stands and
February is my favourite time of the year. Not only is there beautiful summer weather and warm seawater, but this is the time when the Australian and New Zealand Glaucoma Society (ANZGS) Congress takes place! This year’s meeting was in Sydney CBD’s Masonic Centre. It’s a fabulous venue with beautifu
Hamilton-based vitreoretinal specialist Dr Stephen Guest explains how Optos’ ultra-widefield imaging technology is making a difference to his practice and his patients. By Lesley Springall for Optos.